Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)

NCT06699836

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Norton Cancer Institute, Brownsboro Hospital Campus Louisville, Kentucky, United States
View Trial Details
Active, Not Recruiting

Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

NCT06157216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Qilu Hospital of Shandong Univertisy Jinan, Shandong, China
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
  • Jinan Central Hospital Jinan, Shandong, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Active, Not Recruiting

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

NCT04042831

Conditions
Bile Duct Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +9 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

NCT06251973

Conditions
Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details

Related conditions